BioWorld

Feb. 3, 1999

View Archived Issues

Other News To Note

Read More

Removing Menopause-Related Apoptosis Gene Preserved Fertility In Knockout Mice

Read More

BioWorld Today Reader Survey

Read More

Cell Pathways' Prevatac Fails In Phase III Trial

Read More

RPR Gencell Paying Amrad Up To $50M For VEGF-B Rights

Read More

ImmunoGen, SmithKline Sign $45M Deal For Cancer Drug

Read More